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Colostrum Replacer 
and Bovine  
Leukemia Virus  
Seropositivity  
in Calves
To the Editor: Bovine leukemia 
virus (BLV), a deltaretrovirus in the 
family Retroviridae, is the causative 
agent of enzootic bovine leukosis 
(EBL). Although EBL is still endemic 
to the Americas and eastern Europe, 
most countries in western Europe are 
EBL free in accordance with European 
Union legislation; for example, Great 
Britain has held EBL-free status since 
1999. EBL is notifiable to the World 
Organisation for Animal Health (1), 
with disease incursion affecting inter-
national trade. Infection with BLV is 
life-long and persistent; the presence of 
antibodies or integrated proviral DNA 
are indicators of virus exposure. Two 
tests prescribed for international trade 
are the agar gel immunodiffusion test 
(AGIDT) and ELISA (1); these tests 
are used widely for diagnosis (2). 
We report 5 cases that occurred in 
the United Kingdom during 2009, in 
which calves became seropositive for 
BLV after consuming colostrum replac-
er. In Dumfriesshire, Scotland, routine 
serologic screening for BLV detected 
seropositivity in 2 calves, which were 
artificial insemination bull candidates. 
In Newport, Wales, a BLV-seropositive 
calf was identified during pre-export 
testing. And in Yorkshire, England, 2 
more BLV-seropositive calves, also 
artificial insemination bull candidates, 
were identified. All calves were home 
bred, and there was no evidence (as 
documented by serologic testing) or 
history of EBL within the herd. The 
farms were considered to have low risk 
for disease incursion because the intro-
duction of new animals was limited. 
Further inquiry revealed that 
the calves had each been exclusively 
fed a colostrum replacer from North 
America, where BLV is endemic. 
Antibodies to BLV might have been 
present in the colostrum replacer and 
thus passively acquired by the calves, 
resulting in seropositivity. 
The hypothesis was tested by 
monthly blood sampling and ELISA 
analysis for antibodies against BLV 
(Institute Pourquier, Montpellier, 
France). Although the batch of colos-
trum replacer that had been fed to the 
calves from Dumfriesshire was not 
available for investigation, another 
colostrum sample was obtained from 
the same manufacturer for analysis. 
The reconstituted colostrum replacer 
was tested by AGIDT (IDEXX, Bern, 
Switzerland) at the following dilutions: 
neat (manufacturer’s guidelines), 1:2, 
1:4, and 1:8. In addition, 2 commer-
cial ELISA tests (Institute Pourquier 
and IDEXX) were used over a series 
of dilutions to 1:125. All serologic tests 
were conducted according to manufac-
turer’s recommendations. To examine 
the samples for proviral DNA, we con-
ducted PCRs to amplify a 385-bp frag-
ment of the envelope gene (3).
At the various dilutions of colos-
trum replacer, all serologic tests gave 
clearly positive reactions. Proviral PCR 
of the colostrum replacer also returned 
positive results, which were confirmed 
by sequencing. The resultant enve-
lope sequence (GenBank accession 
no. HF545344) was aligned with 23 
other sequences obtained from Gen-
Bank, which encompassed all known 
BLV genotypes. Phylogenetic analysis 
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was conducted as described (4) and 
revealed clustering within genotype 1, 
which is consistent with BLV of North 
American origin (4). The hypothesis 
that colostrum intake had caused the 
seropositivity was supported by the 
declining antibody titers found in se-
rial blood sampling of all 5 calves 
(Table).
The same brand of colostrum re-
placer was used on all 3 farms. For the 
farms in Wales and England, it was 
possible to sample the batch of co-
lostrum powder being used; aliquots 
from each farm were BLV positive by 
AGIDT and ELISA.
Reactions to passively acquired 
antibodies would be expected to de-
crease and become undetectable. After 
exposure to virus and subsequent infec-
tion, antibody titers would not wane to 
undetectable levels. Our results (Table) 
provide evidence that the serologic 
reactions reported here resulted from 
ingestion of the colostrum replacer 
rather than BLV infection. The policy 
and international trade implications of 
such cases for Great Britain have been 
discussed (5). To maintain the disease-
free status of the country, it was nec-
essary to follow up with these cases, 
which inconvenienced farmers because 
of movement restrictions and, conse-
quently, financial loss.
The cases described were all 
linked by the brand of colostrum 
used; however, our additional in-
vestigations found that other brands 
also tested BLV positive by AGIDT 
and thus could cause an effect simi-
lar to that described here. These data 
would therefore be useful to any 
organization involved in BLV sero-
logic surveillance. As a result of this 
investigation, in March 2010 the Eu-
ropean Union banned the import of 
calf colostrum from herds that are not 
EBL free.
Although PCR confirmed the 
presence of BLV proviral DNA in the 
colostrum, detection of such does not 
mean that the colostrum contained 
viable virus. Retroviruses, including 
BLV, are heat labile; thus, it is un-
likely that viable BLV would survive 
the spray-drying production process. 
Whether other agents can survive war-
rants further investigation.
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Table.	Bovine	leukemia	virus	seropositivity	of	calves	fed	colostrum	replacer,	UK,	2009* 
Location 
Time	from	initial	sampling,	mo 
0 1 2 3 4 
Dumfriesshire,	Scotland      
 Calf	1 +++ ++ + IC – 
 Calf	2 +++ + + – – 
Newport,	Wales	      
 Calf	1 ++ ++ NS NS – 
Yorkshire,	England      
 Calf	1 ++ + + NS – 
 Calf	2 ++ + + NS – 
*Tested	by	ELISA	(Institute	Pourquier,	Montpellier,	France).	+++,	strong	positive,	sample	to	positive	
(S/P)	ratio	>200;	++,	positive,	S/P	ratio	>100;	+:	weak	positive,	S/P	ratio	60–99;	–,	negative,	S/P	
ratio	<60;	IC,	inconclusive,	S/P	ratio	60–70;	NS,	not	sampled. 
 
